AstraZeneca receives marketing permission for Olaparib tablet
Olaparib (Lynparza) tablet will be used for treating ovarian and breast cancer in India
Sign in
Sign in
Recover your password.
A password will be e-mailed to you.
Are you ready for EU FMD? Urgency, consistency and planning are key
Vikash Pushpraj, Senior Vice President, rfxcel
Netmeds takes efforts to raise awareness about child abuse
Netmeds marks its territory on the social platform by creating a unique awareness video on #LetMeGrow – In search of Freedom this…
GIBS organises 3rd annual scientific congress in September
The theme for the 3rd Annual Scientific Congress on IC/BPS- GIBS 2018 is 'On The Horizon' wherein world’s top subject experts are…
IIT Mandi ties up with RxDataScience, US
Researchers to apply deep-learning methods and cognitive algorithms for discovering patterns among patient journeys & social…
Indian Pharmacovigilance Day 2018 conference was held at Mumbai recently
Several sessions on medical writing, literature searching, evolution of India's pharmacovigilance initiatives were held at the…
Sun Pharma announces US FDA approval of Cequa to treat dry eye disease
Cequa (cyclosporine ophthalmic solution) 0.09 per cent for topical ophthalmic use is the only dry eye treatment to combine…
Suven Life Sciences announces financial results for quarter ending June 30, 2018
Suven’s income at INR 1998 mn; PAT at INR 388 Mn for the quarter ended June 2018
AvaMed responds to NPPA’s extension of price-capping on knee implants
AvaMed hoped for a better outcome that values quality, safety and clinical results
IIT Roorkee professor awarded GD Naidu award for work in biomedical nanotechnology
Dr P Gopinath has developed an economical and green way to detect and kill cancer cells and a portable nanofibrous material for…